Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PDE4A | P27815 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL865351 | 1.00 | LMNA (0.38) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL1793894 | 1.00 | LMNA (0.38) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL6314530 | 0.98 | LMNA (0.37) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL9689590 | 0.95 | LMNA (0.34) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL8308791 | 0.83 | — | — | |
| SCHEMBL92768 | 0.82 | LMNA (0.41) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL215095 | 0.82 | LMNA (0.41) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL540415 | 0.82 | LMNA (0.41) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL2015790 | 0.82 | LMNA (0.41) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL14808559 | 0.81 | LMNA (0.39) | LMNAL3MBTL1PDE4ATDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112940059-A | Glycosyl modified naphthalimide-polyamine conjugate, preparation method and application thereof | 河南大学 | 2021-06-11 | — | — | CN | claimed |
| CN-115381844-B | Bacterial capsular oligosaccharide derivative, preparation method, pharmaceutical composition and application thereof | 北京大学 | 2024-03-22 | — | — | CN | disclosed |
| WO-2023051684-A1 | BACTERIAL CAPSULAR OLIGOSACCHARIDE DERIVATIVE, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 北京大学 | 2023-04-06 | — | — | WO | disclosed |
| CN-112940059-B | Glycosyl modified naphthalimide-polyamine conjugate, preparation method and application thereof | 河南大学 | 2022-05-27 | — | — | CN | disclosed |
| CN-109072273-B | Method for regulating protein galactosylation profile of recombinant protein by using holo-acetyl galactose | 阿雷斯贸易股份有限公司 | 2022-04-15 | — | — | CN | disclosed |
| CN-112940059-A | Glycosyl modified naphthalimide-polyamine conjugate, preparation method and application thereof | 河南大学 | 2021-06-11 | — | — | CN | disclosed |
| EP-3455363-A1 | METHODS FOR MODULATING PROTEIN GALACTOSYLATION PROFILES OF RECOMBINANT PROTEINS USING PERACETYL GALACTOSE | Ares Trading S.A. (CH) | 2019-03-20 | — | — | EP | disclosed |
| WO-2017194605-A1 | METHODS FOR MODULATING PROTEIN GALACTOSYLATION PROFILES OF RECOMBINANT PROTEINS USING PERACETYL GALACTOSE | ARES TRADING S.A. (CH) | 2017-11-16 | — | — | WO | disclosed |
| US-20080224703-A1 | Method and device for magnetic resonance analysis | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2008-09-18 | — | — | US | disclosed |
| US-5910579-A | Processes for the preparation of αGal(1->4)βGal (1->4) Glc-OR | SYNSORB BIOTECH INC. (CA) | 1999-06-08 | — | — | US | disclosed |
| WO-1998030572-A1 | PROCESSES FOR THE PREPARATION OF αGal(1→4)βGal(1→4)Glc-OR | SYNSORB BIOTECH, INC. (CA) | 1998-07-16 | — | — | WO | disclosed |
| EP-0511917-B1 | Glycosylated prodrugs, process for their preparation and uses thereof | HOECHST SA LAB (FR) | 1996-10-23 | — | — | EP | disclosed |
| US-5561119-A | ANTITUMOR AGENTS | LABORATOIRES HOECHST (FR) | 1996-10-01 | — | — | US | disclosed |
| EP-0511917-A1 | Glycosylated prodrugs, process for their preparation and uses thereof | LABORATOIRES HOECHST S.A. (FR) | 1992-11-04 | — | — | EP | disclosed |